Protocol for an economic evaluation alongside a cluster randomised controlled trial: cost-effectiveness of Learning Clubs, a multicomponent intervention to improve women's health and infant's health and development in Vietnam.
Vietnam
cost – utility analysis
cost-effectiveness analysis
early childhood development
infant’s development
infant’s health
learning clubs intervention
perinatal common mental disorders
return on investment
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
15 12 2019
15 12 2019
Historique:
entrez:
18
12
2019
pubmed:
18
12
2019
medline:
15
12
2020
Statut:
epublish
Résumé
Economic evaluations of complex interventions in early child development are required to guide policy and programme development, but a few are yet available. Although significant gains have been made in maternal and child health in resource-constrained environments, this has mainly been concentrated on improving physical health. The Learning Clubs programme addresses both physical and mental child and maternal health. This study is an economic evaluation of a cluster randomised controlled trial of the impact of the Learning Clubs programme in Vietnam. It will be conducted from a societal perspective and aims to identify the cost-effectiveness and the economic and social returns of the intervention. A total of 1008 pregnant women recruited from 84 communes in a rural province in Vietnam will be included in the evaluation. Health and cost data will be gathered at three stages of the trial and used to calculate incremental cost-effectiveness ratios per percentage point improvement of infant's development, infant's health and maternal common mental disorders expressed in quality-adjusted life years gained. The return on investment will be calculated based on improvements in productivity, the results being expressed as benefit-cost ratios. The trial was approved by Monash University Human Research Ethics Committee (Certificate Number 2016-0683), Australia, and approval was extended to include the economic evaluation (Amendment Review Number 2018-0683-23806); and the Institutional Review Board of the Hanoi School of Public Health (Certificate Number 017-377IDD- YTCC), Vietnam. Results will be disseminated through academic journals and conference presentations. ACTRN12617000442303.
Identifiants
pubmed: 31843831
pii: bmjopen-2019-031721
doi: 10.1136/bmjopen-2019-031721
pmc: PMC6924726
doi:
Banques de données
ANZCTR
['ACTRN12617000442303']
Types de publication
Clinical Trial Protocol
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e031721Informations de copyright
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Lancet Glob Health. 2013 Aug;1(2):e77-e86
pubmed: 25104162
Health Qual Life Outcomes. 2016 Jun 07;14:85
pubmed: 27267367
World Health Organ Tech Rep Ser. 1995;854:1-452
pubmed: 8594834
Pharmacoeconomics. 1998 Mar;13(3):277-88
pubmed: 10178653
J Affect Disord. 2014 May;160:104-12
pubmed: 24447613
Int J Equity Health. 2018 Feb 02;17(1):17
pubmed: 29394933
BMJ Open. 2018 Jul 17;8(7):e023539
pubmed: 30018101
Asia Pac Psychiatry. 2014 Mar;6(1):28-37
pubmed: 24591146
J Pediatr. 1998 Apr;132(4):661-6
pubmed: 9580767
Lancet. 2008 Oct 4;372(9645):1251-62
pubmed: 18676011
Cost Eff Resour Alloc. 2003 Feb 26;1(1):1
pubmed: 12773220
Lancet. 2014 Apr 12;383(9925):1333-54
pubmed: 24263249
Int Health. 2013 Mar;5(1):29-37
pubmed: 24029843
PLoS Med. 2013;10(6):e1001470
pubmed: 23853552
Lancet. 2017 Jan 7;389(10064):77-90
pubmed: 27717614
Pharmacoeconomics. 2008;26(4):269-80
pubmed: 18370563
Bull World Health Organ. 2011 Nov 1;89(11):813-20
pubmed: 22084527
BMC Psychiatry. 2013 Jan 12;13:24
pubmed: 23311374
BMC Pregnancy Childbirth. 2014 Jan 08;14:8
pubmed: 24401012
Health Qual Life Outcomes. 2012 Nov 01;10:132
pubmed: 23116130
Arch Pediatr Adolesc Med. 2011 Jan;165(1):22-7
pubmed: 21199976
Lancet. 2008 Feb 2;371(9610):411-6
pubmed: 18242415
Arthritis Res Ther. 2010;12(5):R177
pubmed: 20860837
Bull World Health Organ. 2010 Oct 1;88(10):737-45
pubmed: 20931058
Ann N Y Acad Sci. 2018 May;1419(1):74-89
pubmed: 29791727
J Affect Disord. 2013 Apr 5;146(2):213-9
pubmed: 23026129
Lancet. 2016 Feb 6;387(10018):e14-e16
pubmed: 26794075
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
Bull World Health Organ. 2012 Feb 1;90(2):139G-149G
pubmed: 22423165
Lancet. 2017 Oct 14;390(10104):1792-1806
pubmed: 28433259
Pediatrics. 2011 May;127(5):849-57
pubmed: 21518715
Science. 2014 May 30;344(6187):998-1001
pubmed: 24876490
Bull World Health Organ. 2006 Dec;84(12):991-8
pubmed: 17242836
Health Qual Life Outcomes. 2017 Oct 11;15(1):199
pubmed: 29020996
Stat Methods Med Res. 2016 Oct;25(5):2036-2052
pubmed: 24346164
Lancet Psychiatry. 2016 May;3(5):415-24
pubmed: 27083119
Value Health. 2013 Mar-Apr;16(2):231-50
pubmed: 23538175
JAMA. 2010 Dec 22;304(24):2716-23
pubmed: 21177506
Lancet. 2007 Jan 13;369(9556):145-57
pubmed: 17223478
Lancet. 2018 May 19;391(10134):2071-2078
pubmed: 29627159
Expert Rev Pharmacoecon Outcomes Res. 2018 Oct;18(5):551-558
pubmed: 29958008
Lancet. 2013 Dec 7;382(9908):1898-955
pubmed: 24309475
Science. 2014 Mar 28;343(6178):1478-85
pubmed: 24675955
BMC Public Health. 2010 Jul 23;10:432
pubmed: 20653934
Lancet. 2017 Jan 7;389(10064):91-102
pubmed: 27717615
Arch Dis Child. 1986 Sep;61(9):849-57
pubmed: 2429622